Skip to main content
logo
Stayble Therapeutics AB (publ) (STO:STABL)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.2050
-0.0100 (-4.65%)
Inactive · Last trade price on Jun 2, 2026

Stayble Therapeutics AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-0.02-----
Revenue Growth
------
Gross Profit
-0.02-----
Operating Income
-10.78-6.97-13.18-24.1-24.95-12.14
Net Income
-10.75-6.93-12.42-23.74-24.53-12.09
Earnings Per Share
--0.12-0.33-0.92-1.77-0.87
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.12.452.214.0812.8537.47
Total Debt
-0.850.850.850.850.85
Net Cash (Debt)
1.11.61.3513.231236.62
Net Cash Growth
-35.93%19.09%-89.83%10.28%-67.24%272.78%
Net Cash Per Share
-0.030.040.510.872.64

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-5.91-6.72--23.54-24.89-9.63
Free Cash Flow
-5.91-6.72--23.54-24.89-9.63
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
------
Profit Margin
------

Valuation
Selected indicators aren't available for this stock.